BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37554942)

  • 1. Histopathological findings affect quantitative values of single photon emission computed tomography in patients with antiresorptive agent-related osteonecrosis of the jaws.
    Okui T; Kobayashi Y; Isomura M; Tsujimoto M; Satoh K; Toyama H
    Fujita Med J; 2023 Aug; 9(3):186-193. PubMed ID: 37554942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
    Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
    Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of morphological findings in computed tomography on the quantitative values in single-photon emission computed tomography for patients with antiresorptive agent-related osteonecrosis of the jaw: a cross-sectional study.
    Kobayashi Y; Okui T; Tsujimoto M; Ikeda H; Satoh K; Kanamori D; Fujii N; Toyama H; Matsuo K
    Ann Nucl Med; 2021 Jul; 35(7):853-860. PubMed ID: 33997910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.
    Hata H; Kitao T; Sato J; Asaka T; Ohga N; Imamachi K; Hirata K; Shiga T; Yamazaki Y; Kitagawa Y
    Sci Rep; 2020 Jul; 10(1):11385. PubMed ID: 32647190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
    An YS; Park DY; Min BH; Lee SJ; Yoon JK
    BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
    Yamamoto Y; Mitsunaga S; Horikawa A; Hino A; Kurihara H
    Ann Nucl Med; 2020 Jan; 34(1):74-79. PubMed ID: 31705367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
    Toshima H; Ogura I
    Dentomaxillofac Radiol; 2020 Dec; 49(8):20200043. PubMed ID: 32491931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
    Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
    Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
    Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging.
    Miyashita H; Kameyama K; Morita M; Nakagawa T; Nakahara T
    Dentomaxillofac Radiol; 2019 Dec; 48(8):20190208. PubMed ID: 31287720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
    Tezuka Y; Ogura I
    Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Watanabe S; Nakajima K; Mizokami A; Yaegashi H; Noguchi N; Kawashiri S; Inokuchi M; Kinuya S
    Ann Nucl Med; 2017 Apr; 31(3):201-210. PubMed ID: 27995542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).
    Baba A; Ojiri H; Goto TK; Ikeda K; Yamauchi H; Ogino N; Mogami T
    Jpn Dent Sci Rev; 2019 Nov; 55(1):58-64. PubMed ID: 30815046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.
    Tohashi K; Nakabayashi M; Kodani I; Kidani K; Ryoke K
    Yonago Acta Med; 2016 Mar; 59(1):45-53. PubMed ID: 27046950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Minami Y; Ogura I
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.
    Watanabe T; Yoshida T; Akizuki S; Yamanaka S; Nakao K; Fukuhara S; Asai K; Uozumi R; Bessho K
    J Bone Miner Metab; 2022 Jul; 40(4):657-662. PubMed ID: 35534635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
    Ogawa R; Ogura I
    Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.